%0期刊文章%@ 2371-4379 I JMIR出版物%V 7% N卡塔尔世界杯8强波胆分析 1% P e31451%关于荷兰2型糖尿病患者使用移动健康应用程序的障碍和驱动因素:解释性顺序设计研究%A Bults,Marloes %A van Leersum,Catharina Margaretha %A Olthuis,Theodorus Johannes Josef %A Bekhuis,Robin Enya Marije %A den Ouden,Marjolein Elisabeth Maria %+技术，萨克森应用科学大学健康与护理研究小组，M.H. Tromplaan 28，恩斯赫德，7513 AB，荷兰，31 620946213,m.bults@saxion.nl %K 2型糖尿病%K自我管理%K移动健康，移动应用程序%K预防%K混合方法研究%K接受%K手机%D 2022 %7 27.1.2022 %9原始论文%J JMIR糖尿病%G英文%X背景:自我监测血糖水平、食物摄入和身体活动支持2型糖尿病(T2DM)患者的自我管理。针对2型糖尿病的移动健康应用程序的开发和可用性有所增加。目的:本研究旨在探讨T2DM患者糖尿病移动健康应用的实际使用情况，以及应用用户和非应用用户的主要障碍和驱动因素。方法:采用解释性顺序设计，首先是基于网络的问卷调查，然后是半结构化的深度访谈。数据收集于2020年7月至12月之间。使用IBM SPSS Statistics (version 25.0)对103名受访者的问卷数据进行分析。对技术接受与使用统一理论(Unified Theory of Acceptance and use of Technology, UTAUT)中应用程序和项目的实际使用情况进行描述性统计。UTAUT包括4个关键结构:性能预期(相信应用程序将有助于改善健康表现)、努力预期(使用应用程序的轻松程度)、社会影响(社会支持)和便利条件(基础设施支持)。 Differences between users and nonusers were analyzed using chi-square tests for individual items. Independent 2-tailed t tests were performed to test for differences in mean scores per the UTAUT construct. In total, 16 respondents participated in the interviews (10 users and 6 nonusers of apps for T2DM). We performed content analysis using a deductive approach on all transcripts, guided by the UTAUT. Results: Regarding actual use, 55.3% (57/103) were nonusers and 44.7% (46/103) were users of apps for T2DM. The main driver for the use of apps was the belief that using apps for managing diabetes would result in better personal health and well-being. The time and energy required to keep track of the data and understand the app were mentioned as barriers. Mean scores were significantly higher among users compared with nonusers of apps for T2DM for the constructs performance expectancy (4.06, SD 0.64 vs 3.29, SD 0.89; P<.001), effort expectancy (4.04, SD 0.62 vs 3.50, SD 0.82; P<.001), social influence (3.59, SD 0.55 vs 3.29, SD 0.54; P=.007), and facilitating conditions (4.22, SD 0.48 vs 3.65, SD 0.70; P<.001). On the basis of 16 in-depth interviews, it was recognized that health care professionals play an important role in supporting patients with T2DM in using apps. However, respondents noticed that their health care professionals were often not supportive of the use of apps for managing diabetes, did not show interest, or did not talk about apps. Reimbursement by insurance companies was mentioned as a missing facilitator. Conclusions: Empowering health care professionals’ engagement is of utmost importance in supporting patients with T2DM in the use of apps. Insurance companies can play a role in facilitating the use of diabetes apps by ensuring reimbursement. %M 35084357 %R 10.2196/31451 %U https://diabetes.www.mybigtv.com/2022/1/e31451 %U https://doi.org/10.2196/31451 %U http://www.ncbi.nlm.nih.gov/pubmed/35084357